guidance

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum…

13 hours ago

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2024 Financial Guidance Ranges

Total Company Revenue increased 14.7% to $461.1 million in the third quarter of 2024 from $402.0 million in the third…

2 weeks ago